Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - Cue Biopharma, Inc. | d923493dex311.htm |
10-K/A - 10-K/A - Cue Biopharma, Inc. | d923493d10ka.htm |
Exhibit 31.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kerri-Ann Millar, certify that:
1. | I have reviewed this Amendment No. 2 to Annual Report on Form 10-K of Cue Biopharma, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 29, 2020
Cue Biopharma, Inc. | ||
By: | /s/ Kerri-Ann Millar | |
Kerri-Ann Millar Vice President, Finance (Principal Financial Officer and Principal Accounting Officer) |